162.116.190.174
IPv4 address
162.116.190.174
An address in Irvine, California, United States, used by Allergan, Inc., announced by AbbVie, Inc. (AS62763). It's a web server on port 80.
Summary
Geolocation
Where the address is, and what that place uses.
- City
- Irvine
- Region
- California
- Postal code
- 92612
- Country
- United States
- Continent
- North America
- Coordinates
- 33.6695, -117.8231
- Timezone
- America/Los_Angeles
Ownership
Who holds the address: the AS announcing it, the registry record, the abuse contact and its name in DNS.
- Company
- Allergan, Inc.
- Domain
- abbvie.com
- Type
- Business
- Registered in
- United States
- AS number
- AS62763
- Name
- AbbVie, Inc.
- Prefix
- 162.116.190.0/24
- RPKI
- Not found
- Type
- Business
- Domain
- abbvie.com
- Registered in
- United States
- Name
- Allergan, Inc.
- Network name
- ALLERGAN
- Organization
- ALLERG
- Status
- allocation
- Registry
- ARIN
- Domain
- abbvie.com
- Name
- technicalmgr
- Phone
- +1-714-246-5446
- Address
- 1 N Waukegan Rd, North Chicago, IL, 60064
- Network
- 162.116.0.0-162.116.255.255
Anonymity
Whether the address hides someone else: a VPN, Tor, a relay, a proxy pool, or a hosting range.
Network
What kind of network it is on: a mobile carrier, a satellite operator, an anycast service, a CDN edge.
Services
What our own internet-wide measurement found listening on it.
- 80 status
- 302
- 80 redirect
- https://myval.allergan.com/vAC/LaunchOnceSiteMinder.aspx?id=10&cmd=http://162.116.190.174/
- 80 server
- BigIP
- 80 seen
- 2026-08-13 to 2026-11-07
00 · Evaluate
Test the real build first.
An evaluation license puts a full current build in your hands, with no sampling, so you can measure it against your own traffic before anyone talks about terms.
01 · License
Then license what you use.
Standard, for detection and decisions inside your own product and operations.
Redistribution, when the data ships onward inside what you sell, priced by scope rather than by seat.
Annual terms, a named contact, and monthly, quarterly or yearly payment.